Is liposomal bupivacaine superior to standard bupivacaine for pain control following minimally invasive thoracic surgery?

Zhang, Yang; Zhao, Liang; Li, Shuangjiang; Liu, Junhua (2020). Is liposomal bupivacaine superior to standard bupivacaine for pain control following minimally invasive thoracic surgery? Interactive cardiovascular and thoracic surgery, 31(2), pp. 199-203. Oxford University Press 10.1093/icvts/ivaa083

Text ivaa083.pdf - Published Version Restricted to registered users only Available under License Publisher holds Copyright. Download (90kB) | Request a copy

A best evidence topic in thoracic surgery was written according to a structured protocol. The question addressed was whether regional liposomal bupivacaine was superior to standard bupivacaine for pain control following minimally invasive thoracic surgery. Altogether 70 papers were found using the reported search, of which 5 papers represented the best evidence to answer the clinical question. The authors, journal, date and country of publication, patient group studied, study type, relevant outcomes and results of these papers are tabulated. Two of the five available studies showed a significant reduction of early narcotic consumption with the regional analgesia using liposomal bupivacaine, one showed a significantly reduced usage of opioid medication during postoperative hour 24-36 among the patients receiving liposomal bupivacaine, and 2 showed no difference in cumulative opioid consumption between the 2 regional analgesia groups. In addition, there was no associated difference in the pain severity scores or the length of hospitalization.

Interest & Impact

Downloads

1 since deposited on 16 Dec 2022
1 in the past 12 months

Citations

5 Citations in Web of Science ®
6 Citations in Scopus

Search

in Google Scholar™

Services

Actions (login required)

Edit item

Actions (login required)

Edit item